SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Emily Brown, Hiddo J.L. Heerspink, Daniel J. Cuthbertson, John Wilding
Topics & Concepts
MedicineGlucagon-like peptide 1 receptorPharmacologyReceptorB2 receptorAgonistInternal medicineBradykininDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer